Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Periwinkles As Drug Factories

October 30, 2006 | A version of this story appeared in Volume 84, Issue 44

Chemists have prodded seedlings of the medicinal periwinkle plant to make a variety of nonnatural terpene indole alkaloids in a process that could help produce hard-to-synthesize drugs (J. Am. Chem. Soc. 2006, 128, 14276). The periwinkle normally produces a treasure trove of natural products, including the anticancer agent vinblastine (shown, Me = methyl, Ac = acetyl), which is assembled in mature plants from two tryptamine-based precursors (tryptamine-derived portion is red). Semisynthetic derivatives of vinblastine continue to show promise in clinical trials, notes Sarah E. O'Connor of MIT. In hopes of easing access to these and other nonnatural vinblastine analogs, O'Connor and Elizabeth McCoy fed periwinkle seedlings various tryptamine derivatives. The seedlings make a variety of complex terpene indole alkaloids from the tryptamine derivatives, including analogs of the precursors from which vinblastine is assembled. Manipulating natural biosynthetic pathways in this way is common in bacteria but it's largely untackled in plants, the researchers note.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.